Culture medium for inducing cartilage differentiation by human mesenchymal stem cells as well as preparation method and use method of culture medium

By adding hepatocyte growth factors and other factors to the chondromic differentiation medium of mesenchymal stem cells, the medium formula is optimized, and the problems of low differentiation efficiency and long time in the existing technology are solved, and efficient chondromic differentiation and The simple preparation process enhances the clinical application value of chondrocytes.

CN119060945APending Publication Date: 2024-12-03XIAN CHAOYUE STEM CELL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311593558.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-11-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing mesenchymal stem cell cartilage-induced differentiation medium has added a variety of factors to the high-glycemic DMEM medium, but the differentiation efficiency is low and the differentiation time is long, making it difficult for chondrocytes to undergo clinical treatment through injection and has low application value.

Method used

Add hepatocyte growth factor (HGF) to the existing culture medium, combined with DMEM high-sugar medium, dexamethasone, L-ascorbic acid, ITS-A and TGF-β3 and optimize the medium formula to promote mesenchymal stem cells The chondrocyte differentiation is carried out by two-dimensional plane culture method to improve differentiation efficiency and shorten the differentiation time.

Benefits of technology

It significantly improves the specific differentiation efficiency of mesenchymal stem cells to chondrocytes, shortens the differentiation time, improves the expression level and application value of chondrocytes, makes chondrocytes easier to inject and treat, and is easy to prepare and use the culture medium.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060945A_ABST
    Figure CN119060945A_ABST
Patent Text Reader

Abstract

The invention discloses a human mesenchymal stem cell induced cartilage differentiation culture medium as well as a preparation method and a use method thereof. The method comprises the following steps: adding L-ascorbic acid mother liquor, dexamethasone mother liquor, ITS-A mother liquor, transforming growth factor-beta3 (TGF-beta3) mother liquor, insulin-like growth factor-1 (IGF-1) mother liquor and hepatocyte growth factor (HGF) mother liquor into a DMEM high-glucose culture medium according to the concentration, uniformly mixing, filtering and sterilizing by using a 0.22 mu m filter, and refrigerating in a refrigerator at 4 DEG C for later use. The hepatocyte growth factor added into an existing culture medium can promote proliferation and migration of mesenchymal stem cells and apoptosis induced by anoikis, can specifically act on formed cartilage cells, has chemotaxis and mitosis-inducing activity on the cartilage cells, and promotes the cartilage cells to synthesize a matrix, so that the cartilage cell culture medium has a good application prospect. Therefore, the specific differentiation of the human mesenchymal stem cells to the cartilage cells is further efficiently promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of culturing stem cells, and in particular relates to a culture medium for inducing cartilage differentiation of human mesenchymal stem cells and a preparation and use method thereof. Background Art

[0002] Stem cells are one of the hottest areas in the current biomedical industry; stem cells are a type of multipotent cell with the ability to self-replicate. Under certain conditions, they can differentiate into a variety of functional cells. According to the developmental stage of stem cells, they can be divided into embryonic stem cells and adult stem cells. Adult stem cells are mostly divided into mesenchymal stem cells, which have abundant sources and strong differentiation ability. Under certain conditions, they have good unidirectional differentiation ability, so they are widely used in regenerative medicine.

[0003] Mesenchymal stem cells can differentiate into chondrocytes or chondrocyte precursor cells under certain conditions. Currently, most studies on mesenchymal stem cell differentiation into cartilage tend to culture them into three-dimensional cell spheres. However, due to their large size and indigestibility, it is difficult to inject the differentiated chondrocytes into the site of cartilage injury for treatment. At the same time, the process of mesenchymal stem cell differentiation into cartilage culture is also time-consuming. Therefore, in order to obtain sufficient mesenchymal stem cell-derived chondrocytes for clinical application, it is necessary to optimize specific culture conditions and perform directional differentiation induction, so as to efficiently obtain sufficient and uniform cartilage tissue cells for injury repair in a short period of time. The existing human mesenchymal stem cell chondrogenic differentiation medium is based on the high-glucose DMEM medium, supplemented with 10% fetal bovine serum (FBS), 1mM sodium pyruvate, 20ug / mL proline, 1XITS, 50μg / mL ascorbic acid, 100nM dexamethasone, and 10ng / mL TGF-β. The medium is used to induce the mesenchymal stem cells of the next generation to differentiate into chondrocytes, and the differentiation culture time lasts for 3-5 weeks. The differentiation efficiency is low, and the differentiated chondrocyte spheres are not easy to be injected for clinical trial treatment, and the application value is low.

[0004] This study changed the induction factors in the process of mesenchymal stem cell differentiation into chondrocytes, allowing mesenchymal stem cells to differentiate into chondrocytes more efficiently during planar culture, while also shortening the culture time of mesenchymal stem cell factor differentiation into chondrocytes.

[0005] Therefore, in order to solve the above problems, this paper proposes a human mesenchymal stem cell induced chondrogenic differentiation culture medium and a preparation and use method thereof. Summary of the invention

[0006] In order to solve the above technical problems, the present invention designs a human mesenchymal stem cell induced chondrogenic differentiation medium and a preparation and use method thereof. Hepatocyte growth factor (HGF) is added to the existing chondrogenic induction differentiation medium, which can specifically act on the formed chondrocytes, has chemotaxis and mitogenic activity to them, and promotes chondrocytes to synthesize matrix, thereby further efficiently promoting the specific differentiation of human mesenchymal stem cells into chondrocytes.

[0007] In order to achieve the above technical effects, the present invention is implemented by the following technical scheme: A culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells, characterized in that it includes the following components:

[0008] DMEM high glucose culture medium, L-ascorbic acid 20-100ug / mL concentration, dexamethasone 10-200nM concentration, ITS-A 0.5-20% volume percentage, transforming growth factor-β3 (TGF-β3) 0.1-20ng / mL concentration, insulin-like growth factor-1 (IGF-1) 0.1-100ng / mL concentration, hepatocyte growth factor (HGF) 0.1~20ng / mL concentration.

[0009] Further, the following components are included:

[0010] DMEM high glucose medium, L-ascorbic acid 50ug / mL concentration, dexamethasone 100nM concentration, ITS-A 1X volume percentage, transforming growth factor β3 (TGF-β3) 5ng / mL concentration, insulin-like growth factor 1 (IGF-1) 50ng / mL concentration, hepatocyte growth factor (HGF) 5ng / mL concentration.

[0011] Another object of the present invention is to provide a method for preparing a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells, characterized in that it comprises the following steps:

[0012] Step 1. Classify and package the required instruments and consumables for sterilization;

[0013] Step 2, prepare the reagent stock solution for use;

[0014] Step 3. Add L-ascorbic acid mother solution, dexamethasone mother solution, transforming growth factor-β3 (TGF-β3) mother solution, insulin-like growth factor-1 (IGF-1) mother solution, hepatocyte growth factor (HGF) mother solution, and insulin-transferrin-selenium-sodium pyruvate (ITS-A) mother solution to DMEM high-glucose culture medium in turn and mix well.

[0015] Step 4: Filter the mixed culture solution through a 0.22um filter membrane to sterilize.

[0016] Another object of the present invention is to provide a method for using a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells, characterized in that it comprises the following steps:

[0017] 1) Cell recovery: cryopreserved umbilical cord mesenchymal stem cells were recovered and cultured with Yokogawa serum-free medium;

[0018] 2) Digestion and passaging: The cells cultured in Youkang serum-free medium for 3 days were digested with trypsin to obtain umbilical cord mesenchymal stem cell suspension;

[0019] 3) Inoculation: The obtained suspension cells are inoculated into a culture dish according to the corresponding number and cultured with Youkang serum-free culture medium;

[0020] 4) Changing the medium: When the cultured cells proliferate to 80% in the culture dish, discard the medium, wash the remaining medium in the culture dish with sterilized PBS, wash twice, and then add mesenchymal stem cell chondrogenic differentiation induction medium to the culture dish to culture the cells;

[0021] 5) Differentiation induction: The cells were cultured in mesenchymal stem cell chondrogenic differentiation medium for 7 days to obtain chondrocytes.

[0022] The beneficial effects of the present invention are:

[0023] Dexamethasone in the culture medium can upregulate the aggrecan of human mesenchymal stem cells by activating the WNT / β-catenin signaling pathway; ascorbic acid can activate the transcription of chondrogenic genes such as Runx2 and Sox9 and promote the expression of type II collagen by activating the ERK signal; TGF-β3 can activate the transcription of chondrogenic-related genes by activating the Smad2 / 3 / 4 signal, thereby promoting the chondrogenic differentiation of mesenchymal stem cells; ITS-A can promote the expression of type II collagen by upregulating the transcriptional expression of the Sox9 gene; hepatocyte growth factor can promote the proliferation, migration and apoptosis induced by anoikis of mesenchymal stem cells. Hepatocyte growth factor can specifically act on the formed chondrocytes, has chemotaxis and mitogenic activity to them, and promotes the synthesis of matrix by chondrocytes, thereby further efficiently promoting the specific differentiation of human mesenchymal stem cells into chondrocytes;

[0024] The human mesenchymal stem cell chondrogenic differentiation medium provided by the present invention can realize the efficient induction differentiation of human umbilical cord mesenchymal stem cells into chondrocytes in a two-dimensional plane and a 3D environment, and the specificity of differentiation into chondrocytes is high. Compared with the 3-6 weeks required for inducing mesenchymal stem cells to differentiate into chondrocytes in the prior art, the human mesenchymal stem cell chondrogenic differentiation medium provided by the present invention can make a large amount of cartilage tissue extracellular matrix represented by type II collagen appear in human mesenchymal stem cells within one week of culture with liquid replacement, and at the same time, the expression level of Sox-9 protein closely related to chondrogenic differentiation is significantly increased, shortening the induction time of human mesenchymal stem cells to differentiate into chondrocytes, and at the same time, the human mesenchymal stem cell chondrogenic differentiation medium provided by the present invention can more efficiently induce the differentiation of mesenchymal stem cells in a two-dimensional plane into chondrocytes, and can more easily obtain a differentiated chondrocyte suspension, making it easier to perform injection treatment in later applications. In addition, the preparation method of the human mesenchymal stem cell chondrogenic differentiation medium provided by the present invention is simple and convenient to use, and can realize stable and efficient chondrogenic differentiation of human mesenchymal stem cells in a two-dimensional plane. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings required for describing the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative work.

[0026] Figure 1 : The effects of different formulations of human mesenchymal stem cell chondrogenic differentiation medium on the expression of chondrogenic differentiation-related genes CollageⅡ and SOX-9 at 7 days of induction;

[0027] Figure 2 : The effects of different formulations of human mesenchymal stem cell chondrogenic differentiation medium on the expression of chondrogenic differentiation-related genes CollageⅡ and SOX-9 at 14 days of induction;

[0028] Figure 3 : Alcian blue staining results of chondrogenic differentiation of human mesenchymal stem cells in different formulations of the present invention at 7 days of induction;

[0029] Figure 4 : The effects of different formulations of human mesenchymal stem cell chondrogenic differentiation medium on the expression of TGF-β1 at 7 days of induction;

[0030] Figure 5: The effect of the chondrogenic differentiation medium of the present invention on the expression of chondrogenic differentiation-related genes CollageⅡ and SOX-9 in human umbilical cord mesenchymal stem cells at 7 days of induction;

[0031] Figure 6 : Alcian blue staining results of chondrogenic differentiation of human umbilical cord mesenchymal stem cells in the chondrogenic differentiation medium of the present invention at 7 days of induction. DETAILED DESCRIPTION

[0032] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] All components involved in the formula of the present invention are conventional products sold on the market. The information of the chondrogenic differentiation induction medium involved in the specific implementation case is as follows:

[0034] Differentiation induction medium 1: the differentiation induction medium mentioned in Example 1 of the present invention without adding the three factors TGF-β3, IGF-1 and HGF.

[0035] Differentiation induction medium 2: the existing human mesenchymal stem cell chondrogenic differentiation medium mentioned in Example 1 of the present invention.

[0036] Differentiation induction medium 3: the human mesenchymal stem cell chondrogenic differentiation medium provided in Example 2 of the present invention.

[0037] Differentiation induction medium 4: the human mesenchymal stem cell chondrogenic differentiation medium provided in Example 3 of the present invention.

[0038] Differentiation induction medium 5: the human mesenchymal stem cell chondrogenic differentiation medium provided in Example 4 of the present invention.

[0039] Induction differentiation medium 6: Human mesenchymal stem cell chondrogenic differentiation induction medium from Saiye Biotechnology Co., Ltd., the product number is HUXUC-9004.

[0040] Example 1

[0041] Screening of formula for chondrogenic differentiation medium of human mesenchymal stem cells

[0042] The present invention screened the components of the culture medium for inducing differentiation of human mesenchymal stem cells into chondrocytes through a large number of experiments. There are two culture mediums selected as controls, namely:

[0043] Differentiation medium 1 without the addition of three chondrogenic factors, TGF-β3, IGF-1 and HGF:

[0044] Dexamethasone 100nM L-Ascorbic Acid 50nM ITS-A 1X

[0045] Existing human mesenchymal stem cell chondrogenic differentiation medium without HGF added 2:

[0046] Dexamethasone 100nM L-Ascorbic Acid 50nM ITS-A 1X TGF-β3 5ng / mL IGF-1 50ng / mL

[0047] The frozen mesenchymal stem cells were revived using the Yokogawa serum-free medium. After 3 days of culture, they were digested with trypsin, resuspended with Yokogawa serum-free medium and inoculated into six-well plates at 1×105 cells / well. After 48 hours, the supernatant was removed after the cell fusion rate reached 80%, and each well was rinsed 3 times with PBS buffer to remove the residual medium. 2 ml / well of induction differentiation medium 1, induction differentiation medium 2, induction differentiation medium 3, induction differentiation medium 4 and induction differentiation medium 5 were added respectively, and the medium was changed every 2-3 days. On the 7th and 14th days of induction, the expression levels of chondrocyte-related genes CollageⅡ and SOX-9 were detected by real-time PCR. The results are shown in Figure 2. Figure 1 and Figure 2 As shown. It shows that by adding hepatocyte growth factor (HGF) to the existing human mesenchymal stem cell differentiation into chondrocyte induction medium, the expression levels of cartilage-related genes CollageⅡ and SOX-9 can be significantly upregulated after 7 days of two-dimensional plane induction differentiation culture (compared with induction differentiation medium 1, induction differentiation medium 2, induction differentiation medium 3 and induction differentiation medium 5, p<0.01 or p<0.05).

[0048] After 7 days of 2D differentiation culture, the degree of induced cartilage differentiation was identified using Alcian blue. Figure 3 As shown, the degree of inducing differentiation of cells into cartilage by the chondrogenic differentiation medium of human mesenchymal stem cells in the present invention is higher. The above results show that the chondrogenic differentiation medium of human mesenchymal stem cells in the present invention has a better chondrogenic differentiation effect on mesenchymal stem cells.

[0049] At the same time, human transforming growth factor β1 (TGF-β1) ELISA kit was used to detect TGF-β1 factor in the culture supernatant. The results are as follows Figure 4 As shown, the human mesenchymal stem cell chondrogenic induction differentiation medium of the present invention can significantly upregulate the expression level of TGF-β1 factor after 7 days of two-dimensional plane induction differentiation culture (compared with induction differentiation medium 1, induction differentiation medium 2, induction differentiation medium 3 and induction differentiation medium 5, p<0.01 or p<0.05).

[0050] Example 2

[0051] Preparation of a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells

[0052] The human mesenchymal stem cell chondrogenic differentiation medium comprises a basic medium high-glucose DMEM and the following components, and their concentrations are:

[0053] Dexamethasone 100nM L-Ascorbic Acid 50nM ITS-A 1X TGF-β3 5ng / mL IGF-1 50ng / mL HGF 3ng / mL

[0054] Preparation method: To the basal culture medium high-glucose DMEM, add dexamethasone mother solution, L-ascorbic acid mother solution, ITS-A mother solution, TGF-β3 mother solution, IGF-1 mother solution and HGF mother solution according to the concentrations of the components mentioned above, mix well and filter with a 0.22 μm filter membrane for sterilization, and then refrigerate in a 4°C refrigerator for use.

[0055] The preparation method of the mother solution of each component is as follows:

[0056] Preparation of L-ascorbic acid mother solution: Take 50 mg of L-ascorbic acid and dissolve it in DMEM medium to obtain 50 μg / μL mother solution, filter and sterilize it with a 0.22 μm filter, divide it into portions according to the required amount each time, and store it at -20°C for future use.

[0057] Preparation of dexamethasone mother solution: Take 1g of dexamethasone, dissolve it in 95% ethanol, prepare it into a 100μM mother solution, and filter it with a 0.22μm filter for sterilization. After packaging according to the required amount each time, store it at -20℃ for future use.

[0058] Preparation of TGF-β3 mother solution: Take 5 mg of TGF-β3, dissolve it in DMEM medium, and prepare it into 5 μg / μL mother solution. Filter and sterilize it with a 0.22 μm filter. Divide it into the required amount each time and store it at -20℃ for future use.

[0059] Preparation of IGF-1 mother solution: Take 1 mg of IGF-1, dissolve it in DMEM medium, and prepare it into 50 μg / μL mother solution. Filter and sterilize it with a 0.22 μm filter. Divide it into the required amount each time and store it at -20℃ for future use.

[0060] Example 3

[0061] Preparation of a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells

[0062] The human mesenchymal stem cell chondrogenic differentiation medium comprises a basic medium high-glucose DMEM and the following components, and their concentrations are:

[0063] Dexamethasone 100nM L-Ascorbic Acid 50nM ITS-A 1X TGF-β3 5ng / mL IGF-1 50ng / mL HGF 5ng / mL

[0064] Preparation method: The same as the preparation method mentioned in Example 2, wherein the concentration of hepatocyte growth factor (HGF) is different.

[0065] The frozen mesenchymal stem cells were revived using the serum-free medium of Yokohama. After 3 days of culture, they were digested with trypsin, resuspended in the serum-free medium of Yokohama, and cultured at a rate of 1×10 5 100 cells / well were inoculated into a six-well plate. After 48 hours, the supernatant was removed after the cell fusion rate reached 80%. Each well was rinsed 3 times with PBS buffer to remove the residual culture medium. 2 ml / well of induction differentiation medium 1, induction differentiation medium 4 and induction differentiation medium 6 were added respectively. The medium was changed every 2-3 days. On the 7th day of two-dimensional plane induction, the expression levels of chondrocyte-related genes CollageⅡ and SOX-9 were detected by real-time PCR. The results are shown in the figure. Figure 5 The expression levels of chondrogenesis-related genes CollageⅡ and SOX-9 during the chondrogenesis-induced differentiation of human mesenchymal stem cells of the present invention are shown (compared with induction differentiation medium 1 and induction differentiation medium 6, p<0.01).

[0066] The frozen mesenchymal stem cells were revived using the serum-free medium of Youkang. After 3 days of culture, they were digested with trypsin and resuspended in differentiation induction medium 4 and differentiation induction medium 6, respectively. 1×10 5 After centrifugation, carefully place the cells in the incubator for culture. After 24 hours, carefully blow off the spheroid cells from the wall of the centrifuge tube and let them hang in the culture medium and change the medium. Change the medium every 2-3 days. On the 7th day, fix the obtained cell spheres and use Alcian blue to identify the degree of induced cartilage differentiation. The results are as follows: Figure 6 As shown, the degree of inducing differentiation of cells into cartilage by the chondrogenic differentiation medium of human mesenchymal stem cells in the present invention is higher. The above results show that the chondrogenic differentiation medium of human mesenchymal stem cells in the present invention has a better chondrogenic differentiation effect on mesenchymal stem cells.

[0067] Example 4

[0068] Preparation of a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells

[0069] The human mesenchymal stem cell chondrogenic differentiation medium comprises a basic medium high-glucose DMEM and the following components, and their concentrations are:

[0070] Dexamethasone 100nM L-Ascorbic Acid 50nM ITS-A 1X TGF-β3 5ng / mL IGF-1 50ng / mL HGF 7ng / mL

[0071] Preparation method: The same as the preparation method mentioned in Example 2, wherein the concentration of hepatocyte growth factor (HGF) is different.

[0072] The results of the above embodiments show that compared with the existing human mesenchymal stem cell chondrogenic differentiation medium on the market, the present invention has the characteristics of rapidly inducing human mesenchymal stem cells to differentiate into chondrocytes in a two-dimensional plane, and also has the characteristic of significantly fast induction speed in the process of inducing cell aggregation into spheres, has a good induction differentiation effect on human mesenchymal stem cells, and has a simple preparation process, easy to use, and a stable culture induction process.

Claims

1. A culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells, characterized in that: Includes the following components: DMEM high-glucose culture medium, L-ascorbic acid 20-100ug / mL concentration, dexamethasone 10-200nM concentration, ITS-A 0.5-20% volume percentage, transforming growth factor-β3 (TGF-β3) 0.1-20ng / mL concentration, insulin-like growth factor-1 (IGF-1) 0.1-100ng / mL concentration, hepatocyte growth factor (HGF) 0.1~20ng / mL concentration.

2. A medium for inducing chondrogenic differentiation of human mesenchymal stem cells according to claim 1, characterized in that: Includes the following components: DMEM high glucose medium, L-ascorbic acid 50ug / mL concentration, dexamethasone 100nM concentration, ITS-A 1X volume percentage, transforming growth factor β3 (TGF-β3) 5ng / mL concentration, insulin-like growth factor 1 (IGF-1) 50ng / mL concentration, hepatocyte growth factor (HGF) 5ng / mL concentration.

3. The method for preparing a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells according to claim 1, characterized in that: The following steps are involved: Step 1. Classify and package the required instruments and consumables for sterilization; Step 2, prepare the reagent stock solution for use; Step 3. Add L-ascorbic acid mother solution, dexamethasone mother solution, transforming growth factor-β3 (TGF-β3) mother solution, insulin-like growth factor-1 (IGF-1) mother solution, hepatocyte growth factor (HGF) mother solution, and insulin-transferrin-selenium-sodium pyruvate (ITS-A) mother solution to DMEM high-glucose culture medium in turn and mix well. Step 4: Filter the mixed culture solution through a 0.22um filter membrane to sterilize.

4. The method for using a culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells according to claim 1, characterized in that: The following steps are involved: 1) Cell recovery: cryopreserved umbilical cord mesenchymal stem cells were recovered and cultured with Yokogawa serum-free medium; 2) Digestion and passaging: The cells cultured in Youkang serum-free medium for 3 days were digested with trypsin to obtain umbilical cord mesenchymal stem cell suspension; 3) Inoculation: The obtained suspension cells are inoculated into a culture dish according to the corresponding number and cultured with Youkang serum-free culture medium; 4) Changing the medium: When the cultured cells proliferate to 80% in the culture dish, discard the medium, wash the remaining medium in the culture dish with sterilized PBS, wash twice, and then add mesenchymal stem cell chondrogenic differentiation induction medium to the culture dish to culture the cells; 5) Differentiation induction: The cells were cultured in mesenchymal stem cell chondrogenic differentiation medium for 7 days to obtain chondrocytes.